MYC translocation and/or BCL2 protein expression are associated with poor prognosis in diffuse large B-cell lymphoma

• Material Type: 博士論文
• Title: MYC translocation and/or BCL2 protein expression are associated with poor prognosis in diffuse large B-cell lymphoma
• Author/Editor: Kawamoto, Keisuke
• Publication, Distribution, etc.: 新潟大学
• Publication Date: 2017-03-23
• Publication Date (W3CDTF): 2017-03-23
• Alternative Title: MYC translocation and/or BCL2 protein expression are associated with poor prognosis in diffuse large B-cell lymphoma; MYC遺伝子転座とBCL2蛋白発現はいずれもびまん性大細胞型B細胞リンパ腫の予後不良因子となる
• Degree grantor/type: 新潟大学
• Date Granted: 2017-03-23
• Date Granted (W3CDTF): 2017-03-23
• Dissertation Number: 甲第4277号
• Degree Type: 博士（医学）
• Conferring No. (Dissertation): 甲第4277号
• Text Language Code: eng
• Subject Heading: BCL2; BCL6; diffuse large B‐cell lymphoma; MYC; prognostic factor
• Note (General): Genomic alterations and protein expression levels have been established as prognostic factors for survival in patients with diffuse large B‐cell lymphoma (DLBCL). In particular, double‐hit DLBCL (DHL), which exhibits translocations in MYC and BCL2 and/or BCL6, is known to be associated with a poor prognosis. However, the clinical significance of gene alterations and protein expression levels for MYC, B‐cell lymphoma (BCL)2, and BCL6 are unclear. In this study, we analyzed 61 adult patients diagnosed with DLBCL without DHL, who were treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone, or similar regimens. There were no differences in the distribution of MYC expression rates among the different MYC gene statuses. In log–rank tests, MYC translocation was a prognostic factor for overall survival (OS; P = 0.011), whereas BCL2 and BCL6 translocation were not prognostic indicators (P = 0.999 and P = 0.925, respectively). Although the expression levels of MYC and BCL6 were not significantly associated with OS, the expression of BCL2 was a prognostic factor for OS (P = 0.027). Furthermore, copy number gains in the MYC, BCL2, and BCL6 genes did not affect OS. MYC translocation (hazard ratio, 4.769; range, 1.518–14.98; P = 0.007) and BCL2 protein expression (hazard ratio, 3.072; range, 1.002–9.413; P = 0.049) were independent prognostic factors for survival in multivariate analyses. In conclusion, MYC translocation and BCL2 expression may need to be investigated at the initial diagnosis to predict prognosis in patients with DLBCL.; 学位の種類: 博士（医学）. 報告番号: 甲第4277号. 学位記番号: 新大院博（医）甲第755号. 学位授与年月日: 平成29年3月23日; Cancer Science 2016 Jun; 107(6): 853–861.; 新大院博（医）甲第755号; 元資料の権利情報 : Copyright © 1999 - 2017 John Wiley & Sons, Inc. All Rights Reserved
• DOI: info:doi/10.1111/cas.12942; https://doi.org/info:doi/10.1111/cas.12942
• Persistent ID (NDL): info:ndljp/pid/10371278; https://dl.ndl.go.jp/pid/10371278
• Collection: 障害者向け資料
• Collection (Materials For Handicapped People:1): テキストデータ
• Collection (particular): 国立国会図書館デジタルコレクション > デジタル化資料 > 博士論文; https://dl.ndl.go.jp/collections/A00014
• Acquisition Basis: 博士論文（自動収集）
• Date Accepted (W3CDTF): 2017-07-03T04:10:06+09:00
• Date Created (W3CDTF): 2019-08-05
• Format (IMT): application/pdf
• Access Restrictions: 国立国会図書館内限定公開
• Service for the Digitized Contents Transmission Service: 図書館・個人送信対象外
• Availability of remote photoduplication service: 可
• Periodical Title (URI): http://hdl.handle.net/10191/47621
• Data Provider (Database): 国立国会図書館 : 国立国会図書館デジタルコレクション; https://dl.ndl.go.jp